198 related articles for article (PubMed ID: 24592997)
1. Diagnostic performance of serum macrophage inhibitory cytokine-1 in pancreatic cancer: a meta-analysis and meta-regression analysis.
Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
DNA Cell Biol; 2014 Jun; 33(6):370-7. PubMed ID: 24592997
[TBL] [Abstract][Full Text] [Related]
2. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
3. Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies.
Yang Y; Yan S; Tian H; Bao Y
Medicine (Baltimore); 2018 Mar; 97(9):e9994. PubMed ID: 29489701
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of diagnostic value of serum Carbohydrate antigen 199 in pancreatic cancer.
Zhang Y; Jiang L; Song L
Minerva Med; 2016 Feb; 107(1):62-9. PubMed ID: 26824636
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasonography in qualitative diagnosis of sentinel lymph node metastasis in breast cancer: A meta-analysis.
Zhang YX; Wang XM; Kang S; Li X; Geng J
J Cancer Res Ther; 2015; 11(4):697-703. PubMed ID: 26881504
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of contrast-enhanced ultrasound for renal cell carcinoma: a meta-analysis.
Wang C; Yu C; Yang F; Yang G
Tumour Biol; 2014 Jul; 35(7):6343-50. PubMed ID: 24659450
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound and contrast-enhanced computed tomography for differentiating mass-forming pancreatitis from pancreatic ductal adenocarcinoma: a meta-analysis.
Yang J; Huang J; Zhang Y; Zeng K; Liao M; Jiang Z; Bao W; Lu Q
Chin Med J (Engl); 2023 Sep; 136(17):2028-2036. PubMed ID: 36728948
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the diagnostic role of human telomerase activity from pancreatic juice in pancreatic cancer.
Wang S; Chen X; Tang M
Tumour Biol; 2014 Aug; 35(8):7897-904. PubMed ID: 24828013
[TBL] [Abstract][Full Text] [Related]
9. ABCB1 C3435T polymorphism and the risk of coronary heart disease: a meta-analysis.
Jin Y; Wang Q; Wang G; Zhang X; Yan B; Hu W
Genet Test Mol Biomarkers; 2014 Mar; 18(3):164-73. PubMed ID: 24328528
[TBL] [Abstract][Full Text] [Related]
10. Relationship of PTTG expression with tumor invasiveness and microvessel density of pituitary adenomas: a meta-analysis.
Li Y; Zhou LP; Ma P; Sui CG; Meng FD; Tian X; Fu LY; Jiang YH
Genet Test Mol Biomarkers; 2014 Apr; 18(4):279-85. PubMed ID: 24611443
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in interleukin genes and susceptibility to IgA nephropathy: a meta-analysis.
Liu DJ; Liu Y; Ran LM; Li DT
DNA Cell Biol; 2014 Jun; 33(6):345-54. PubMed ID: 24592969
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of ultrasound superb microvascular imaging for breast tumor: a meta-analysis.
Zhong L; Wang C
Med Ultrason; 2020 Sep; 22(3):313-318. PubMed ID: 32898204
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Urine Cytology in Bladder Cancer. A Meta-Analysis.
Xie Q; Huang Z; Zhu Z; Zheng X; Liu J; Zhang M; Zhang Y
Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):38-44. PubMed ID: 27363065
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-223 in gastrointestinal cancers: A systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Mesgari M; Sahebkar A
Eur J Clin Invest; 2021 Feb; 51(2):e13448. PubMed ID: 33244751
[TBL] [Abstract][Full Text] [Related]
16. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
Li S; Yang X; Yang J; Zhen J; Zhang D
Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.
Han L; Chen W; Zhao Q
Tumour Biol; 2014 Mar; 35(3):2473-80. PubMed ID: 24218336
[TBL] [Abstract][Full Text] [Related]
18. Value of diffusion-weighted imaging for the discrimination of pancreatic lesions: a meta-analysis.
Wu LM; Xu JR; Hua J; Gu HY; Zhang XF; Lu Q; Hu JN
Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):134-42. PubMed ID: 22241215
[TBL] [Abstract][Full Text] [Related]
19. Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer.
Li X; Guo X; Li H; Lin H; Sun Y
Tumour Biol; 2014 Jun; 35(6):5281-6. PubMed ID: 24510349
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasonography for the diagnosis of small hepatocellular carcinoma: a meta-analysis and meta-regression analysis.
Niu Y; Huang T; Lian F; Li F
Tumour Biol; 2013 Dec; 34(6):3667-74. PubMed ID: 23807679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
